Linjie Guo

2 ta ish

Baylor College of Medicine

1. Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy

   Andras Heczey, Daofeng Liu, Gengwen Tian +10

   Maqola20144 iqtibos

   ABIABI:AkademIndex/2026.other.340832

2. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity

   Wenpeng Li, Linjie Guo, Purva Rathi +8

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.340848